Parsonage-Turner Syndrome: Rare Brachial Neuritis Affecting 1-3 per 100,000
Parsonage-Turner syndrome (PTS), or neuralgic amyotrophy, is a rare inflammatory brachial plexopathy.
Epidemiology
- Incidence: 1–3 / 100,000 person-years.
- Male:female ≈ 2:1.
- Peak onset: 20–40 years (range: childhood to elderly).
Typical Course
- Acute pain: Sudden, severe shoulder/upper arm/neck pain (days to weeks).
- Weakness/atrophy: Follows pain; specific to affected nerve branches (suprascapular, axillary, long thoracic, etc.).
- Sensory loss: Variable, often less prominent.
- Recovery: Months to years; ~70–90% good functional recovery, but residual weakness common.
- Infection (viral, bacterial), vaccination, surgery, strenuous exercise, trauma, autoimmune flares.
- Genetic predisposition (SEPT9 mutations in hereditary neuralgic amyotrophy).
- Clinical + EMG/NCS (denervation in specific myotomes).
- MRI brachial plexus (T2 hyperintensity, enhancement).
- Pain control (NSAIDs, gabapentinoids, short opioids).
- Early PT to prevent contractures, maintain ROM.
- Corticosteroids (controversial; may help if early).
Triggers
Diagnosis & Management
Genetic Disorders - Related Articles
- Acute Flaccid Myelitis (AFM) Case Definition: Asymmetric Weakness, Flaccid Paralysis, MRI Gray Matter Lesions
- Congenital Disorders: Understanding Chromosomal Abnormalities
- Parsonage-Turner Syndrome (Neuralgic Amyotrophy): Clinical Overview
- ABO Blood Type Inheritance: Can Type A and Type B Parents Have a Type O Child?
- Angelman Syndrome Carrier Frequency: Current Knowledge
- Congenital Hydrocephalus: Understanding Neural Tube Defects
- Genetic Factors in Cardiovascular Disease: Understanding Your Risk
